Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 1/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13319104 | 0.80 | TYMP (0.50) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL23522670 | 0.78 | TYMP (0.48) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL19165321 | 0.75 | TYMP (0.44) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL24625465 | 0.74 | TYMP (0.46) | TYMPKDM4EMEN1KMT2AMAPT | |
| SCHEMBL7135870 | 0.74 | MAPT (0.52) | TYMPKDM4EMEN1KMT2AMAPT | |
| SCHEMBL2478481 | 0.71 | TYMP (0.47) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL9338973 | 0.70 | TYMP (0.46) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL19924792 | 0.68 | TYMP (0.41) | TYMPGRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL3545 | 0.68 | L3MBTL1 (0.57) | KDM4EMEN1KMT2AMAPTGAA | |
| SCHEMBL16291133 | 0.68 | L3MBTL1 (0.57) | KDM4EMEN1KMT2AMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10374258-B2 | Cyclobutenedione derivative, nonaqueous electrolytic solution, and lithium ion secondary battery | NEC CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20170210764-A1 | CYCLOBUTENEDIONE DERIVATIVE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND LITHIUM ION SECONDARY BATTERY | NEC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170210764-A1 | CYCLOBUTENEDIONE DERIVATIVE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND LITHIUM ION SECONDARY BATTERY | NEC CORPORATION (JP) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374258-B2 | Cyclobutenedione derivative, nonaqueous electrolytic solution, and lithium ion secondary battery | HSD17B11, HSD17B7, HSD17B2 | TYMP 3352/4885GRIN2D 1015/4885GRIN3B 1253/4885 |
| US-20170210764-A1 | CYCLOBUTENEDIONE DERIVATIVE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND LITHIUM ION SECONDARY BATTERY | HSD17B11, HSD17B7, HSD17B2 | TYMP 3352/4885GRIN2D 1015/4885GRIN3B 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.